CIK 0000316709 · Large accelerated filer
SCHWAB CHARLES CORP
Sign in to watch- Ticker
- SCHW
- Exchange
- NYSE
- Industry
- Security Brokers, Dealers & Flotation Companies
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943025021
- Phone
- 817-859-5000
- Business address
- 3000 SCHWAB WAY, WESTLAKE, TX, 76262
Securities
- SCHW Charles Schwab Corporation (The) Common Stock NYSE
- SCHW-PD The Charles Schwab Corporation Depositary Shares each representing 1/40th interest in a share of 5.95% Non-Cumulative Perpetual Preferred Stock, Series D NYSE
- SCHW-PJ The Charles Schwab Corporation Depositary Shares, Each Representing a 1/40th Interest in a Share of 4.450% Non-Cumulative Perpetual Preferred Stock, Series J NYSE
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $69,957,188
- in 12 filings, $1.6M under 10b5-1 plans
Net −$69,957,188. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Schwab Charles R. −$39.0M Co-Chairman sold <1% of stake
- Bettinger Walter W −$28.2M Co-Chairman sold 29% of stake
- Hathi Neesha −$1.6M MD, Head Wealth Adv, Bnk, Tst sold 74% of stake
- Schwab-Pomerantz Carolyn −$1.0M Director sold <1% of stake
- Beatty Jonathan S −$111K MD, Head of Advisor Services sold 9% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-04-22 | Schwab-Pomerantz Carolyn Director | Sale | −6,897 | $76.77 | $529K | 1,545,593.66 |
| 2025-04-22 | Schwab-Pomerantz Carolyn Director | Option exercise · Nonqualified Stock Option (right to buy) | −6,897 | 0 | ||
| 2025-04-21 | HERRINGER FRANK C Director | Option exercise | +8,548 | $31.21 | $267K | 9,204 |
| 2025-04-21 | HERRINGER FRANK C Director | Sale | −3,592 | $74.26 | $267K | 172,162 |
| 2025-04-21 | HERRINGER FRANK C Director | Option exercise · Nonqualified Stock Option (right to buy) | −8,548 | 0 | ||
| 2025-04-03 | Schwab-Pomerantz Carolyn Director | Sale 10b5-1 | −12,253 | $74.89 | $918K | 1,547,740.66 |
| 2025-04-03 | Schwab-Pomerantz Carolyn Director | Sale 10b5-1 | −2,147 | $75.20 | $161K | 1,545,593.66 |
| 2025-04-03 | Schwab-Pomerantz Carolyn Director | Sale 10b5-1 | −8,350 | $74.90 | $625K | 506,979 |
| 2025-04-03 | Schwab-Pomerantz Carolyn Director | Sale 10b5-1 | −1,250 | $75.22 | $94K | 505,729 |
| 2025-04-01 | Brown Marianne Catherine Director | Grant or award · Restricted Stock Units | +483 | 6,094.51 | ||
| 2025-04-01 | Ruffel Charles A. Director | Grant or award · Nonqualified Stock Option (right to buy) | +1,567 | 1,567 | ||
| 2025-04-01 | Ellis Stephen A Director | Grant or award · Restricted Stock Units | +435 | 11,220.87 | ||
| 2025-04-01 | HERRINGER FRANK C Director | Grant or award · Restricted Stock Units | +266 | 148,579.01 | ||
| 2025-04-01 | HERRINGER FRANK C Director | Grant or award · Nonqualified Stock Option (right to buy) | +1,078 | 1,078 | ||
| 2025-04-01 | Woolway Paul V MD, Chief Banking Officer | Sale 10b5-1 | −2,980 | $77.36 | $231K | 46,224.11 |
| 2025-04-01 | Woolway Paul V MD, Chief Banking Officer | Sale 10b5-1 | −400 | $77.96 | $31K | 45,824.11 |
| 2025-03-31 | Ricketts Todd M Director | Gift | +290,608 | 525,805 | ||
| 2025-03-24 | Woolway Paul V MD, Chief Banking Officer | Option exercise 10b5-1 | +8,614 | $41.98 | $362K | 33,767 |
| 2025-03-24 | Woolway Paul V MD, Chief Banking Officer | Sale 10b5-1 | −8,614 | $80.00 | $689K | 49,204.11 |
| 2025-03-24 | Woolway Paul V MD, Chief Banking Officer | Option exercise · Nonqualified Stock Option (right to buy) 10b5-1 | −8,614 | 17,227 |
Page 21 of 22 · 422 trades